Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer?

Biochimica Et Biophysica Acta
A Salameh, S Dhein


Intercellular communication in many organs is maintained via intercellular gap junction channels composed of connexins, a large protein family with a number of isoforms. This gap junction intercellular communication (GJIC) allows the propagation of action potentials (e.g., in brain, heart), and the transfer of small molecules which may regulate cell growth, differentiation and function. The latter has been shown to be involved in cancer growth: reduced GJIC often is associated with increased tumor growth or with de-differentiation processes. Disturbances of GJIC in the heart can cause arrhythmia, while in brain electrical activity during seizures seems to be propagated via gap junction channels. Many diseases or pathophysiological conditions seem to be associated with alterations of gap junction protein expression. Thus, depending on the target disease opening or closure of gap junctions may be of interest, or alteration of connexin expression. GJIC can be affected acutely by changing gap junction conductance or--more chronic--by altering connexin expression and membrane localisation. This review gives an overview on drugs affecting GJIC.


Nov 1, 1992·Pflügers Archiv : European journal of physiology·B R Takens-Kwak, H J Jongsma
Feb 1, 1990·The American Journal of Physiology·D C Spray, J M Burt
Mar 1, 1991·The American Journal of Physiology·J M BurtB N Minnich
Oct 1, 1987·The American Journal of Physiology·J M Burt
Oct 15, 1987·Experientia·R Weingart, P Maurer
Oct 1, 1989·Pflügers Archiv : European journal of physiology·A Rüdisüli, R Weingart
Aug 15, 1989·Experientia·T ArgentieriJ R Wiggins
Sep 1, 1987·Chemical & Pharmaceutical Bulletin·Y KohamaK Yokoyama
Aug 1, 1987·Pflügers Archiv : European journal of physiology·P Maurer, R Weingart
Jul 14, 1966·Annals of the New York Academy of Sciences·W R Loewenstein
Mar 30, 1984·Biochemical and Biophysical Research Communications·W C De Mello
Jan 1, 1982·Journal of Pharmacobio-dynamics·S AonumaY Fujisawa
Aug 1, 1981·The Journal of Cell Biology·R F Fallon, D A Goodenough
Apr 1, 1994·Journal of Cardiovascular Pharmacology·W C De Mello
Mar 1, 1995·Circulation Research·B J DarrowE C Beyer
Feb 24, 1995·The Journal of Biological Chemistry·Z Q ChenS J Lye
Feb 22, 1994·Proceedings. Biological Sciences·W YuR Werner
May 1, 1993·Pflügers Archiv : European journal of physiology·P N Münster, R Weingart
May 1, 1993·Experimental Cell Research·K L PuranamJ P Revel
Feb 9, 1996·Cell·N M Kumar, N B Gilula
Aug 1, 1996·Circulation Research·P Rouet-BenzinebB Crozatier
Mar 1, 1996·Biophysical Journal·G E MorleyM Delmar

❮ Previous
Next ❯


Feb 19, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·S DheinF-W Mohr
Nov 28, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Stefan DheinFriedrich-Wilhelm Mohr
Feb 15, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Aida Salameh, Stefan Dhein
Nov 29, 2007·Journal of Computational Neuroscience·Corrado CalìMichele Giugliano
Nov 24, 2011·Neuroscience Bulletin·Miao-Miao Jin, Zhong Chen
Jul 10, 2013·European Journal of Pharmacology·Ada PopoloAldo Pinto
Apr 20, 2013·Neuropharmacology·Vytas K Verselis, Miduturu Srinivas
Jun 19, 2009·Cardiovascular Research·Sevasti-Maria ChaldoupiHarold V M van Rijen
Apr 21, 2010·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Georges PointisDominique Segretain
Nov 1, 2012·PloS One·Jianjin HuangLing Ding
Jan 1, 2012·Biomicrofluidics·Cédric BathanySusan Z Hua
Dec 24, 2009·Canadian Journal of Physiology and Pharmacology·Narcis TribulovaSeibu Mochizuki
Feb 3, 2016·Molecular Pharmaceutics·Julien Varennes, Andrew Mugler
Oct 4, 2015·Progress in Retinal and Eye Research·Helen V Danesh-MeyerColin R Green
Jan 23, 2016·Proceedings of the National Academy of Sciences of the United States of America·David EllisonAndre Levchenko
Jul 27, 2010·Experimental Neurology·Shenton S L ChewHelen V Danesh-Meyer
Oct 24, 2009·Vascular Pharmacology·Narcis TribulovaTomas Soukup
Jan 24, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Grzegorz R Juszczak, Artur H Swiergiel
Jul 1, 2009·Developmental Neurobiology·Mônica MarinsJoão R L Menezes
Apr 11, 2009·Journal of Neuroscience Research·Marina Concli LeiteCarlos-Alberto Gonçalves
Mar 21, 2007·International Journal of Cancer. Journal International Du Cancer·Qingchang LiKatsuhiko Enomoto
Nov 30, 2006·Annals of the New York Academy of Sciences·Robert G GourdieAndrew W Hunter
Jan 12, 2012·Developmental Neurobiology·Andressa S FreitasJoão R L Menezes
Feb 18, 2014·British Journal of Pharmacology·Stephen P H AlexanderUNKNOWN CGTP Collaborators
Oct 21, 2009·Journal of Neurochemistry·Shanthini MylvaganamMichael O Poulter
Dec 20, 2005·Biochimica Et Biophysica Acta·Jean-Claude Hervé
Dec 20, 2005·Biochimica Et Biophysica Acta·Jean-Claude HervéThomas W White
Jun 2, 2015·Canadian Journal of Physiology and Pharmacology·Jan SlezakMiroslav Barancik
Jul 11, 2006·Medical Hypotheses·Somayeh MahdaviMostafa Rezaei-Tavirani
Jul 15, 2015·Journal of Cellular and Molecular Medicine·Kun GaoJian Yao
Jan 15, 2015·Bioscience Reports·Mariana C FioriLuis G Cuello
May 20, 2015·Biochemical and Biophysical Research Communications·Eri OyanagiHiromi Yano
Mar 4, 2015·Journal of Electrocardiology·Narcis TribulovaCsilla Viczenczova
Jun 15, 2011·Neuroscience and Biobehavioral Reviews·Ekrem Dere, Armin Zlomuzica
Jan 17, 2012·Biochimica Et Biophysica Acta·Aida Salameh, Stefan Dhein
Nov 4, 2009·Biochimica Et Biophysica Acta·Brynjar FossØystein Bruserud
Nov 19, 2014·Frontiers in Physiology·Stefan DheinFriedrich-Wilhelm Mohr
May 23, 2014·Frontiers in Physiology·Shanthini MylvaganamPeter L Carlen
Feb 9, 2017·Journal of Applied Toxicology : JAT·Qingping LiuQing Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.